跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EXEMESTANO AUROVITAS 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
EXEMESTANO AUROVITAS 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
EXEMESTANO AUROVITAS 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Eugia Pharma (Malta) Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 30, 2024
Approval ID
42600a3ee9673f31
Company
Eugia Pharma (Malta) Limited
Type
Standard
Approval Details
Approval Id
42600a3ee9673f31
Drug Cima Aemps Name
EXEMESTANO AUROVITAS 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
89842
Holder Company Name
Eugia Pharma (Malta) Limited
Marketing Company Name
Aurovitas Spain, S.A.U.
Authorization Date
2024-09-30
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
25 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Eugia Pharma (Malta) Limited
Active Ingredients
EXEMESTANO
25 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 30, 2024
Approval ID
42600a3ee9673f31
Type
Standard
Back to CIMA-AEMPS Approvals